...
首页> 外文期刊>Journal of commercial biotechnology >Challenges for Transformative Innovation in Emerging Digital Health Organizations: Advocating Service Design to Address the Multifaceted Healthcare Ecosystem
【24h】

Challenges for Transformative Innovation in Emerging Digital Health Organizations: Advocating Service Design to Address the Multifaceted Healthcare Ecosystem

机译:新兴数码卫生组织转型性创新的挑战:倡导服务设计以解决多方面的医疗保健生态系统

获取原文
获取原文并翻译 | 示例

摘要

This article uses mini - case studies of three early stage organizations that pursued different pathways or models for bringing emerging, transformative digital technologies to the healthcare market.These organizations were each focused on different applications of digital health: Stentor was a venture capital backed, university spinoff focused in the field of digital radiology; Omnyx was formed as a joint venture (JV) by an academic medical center and industrial partner to transform the field of digital pathology; and, IBM Watson operating as an IBM unit, focused on the promise of artificial intelligence and machine learning for broad uses in cancer diagnosis and treatment.Each took a different organizational and business model path that resulted in mixed outcomes.While there are always many reasons for success or failure, we observe that these digital healthcare markets are more complex than typical consumer or technology markets.While any solution in healthcare demands patient centricity; healthcare markets additionally require a strong understanding and appreciation of the supporting ecosystem or network consisting of physicians and providers; and of constraints from payers and regulators.The value propositions of each member of the ecosystem must be understood and addressed.To meet this challenge, we advocate the formation of an integrated multidisciplinary commercialization team that addresses the multidimensional value proposition across the company life cycle.And importantly, that team should work collaboratively, and include service design as a key team member - along with the technology, business, marketing, reimbursement, and regulatory components.
机译:本文使用了三个早期组织的小型案例研究,这些组织追求不同的途径或模式,将新兴的、变革性的数字技术引入医疗市场。这些组织都专注于数字健康的不同应用:Stentor是一家风险投资支持的、专注于数字放射领域的大学附属公司;Omnyx是由一个学术医学中心和行业合作伙伴成立的合资企业(JV),旨在改造数字病理学领域;IBM Watson作为IBM的一个部门,专注于人工智能和机器学习在癌症诊断和治疗中的广泛应用。每个人都采取了不同的组织和商业模式,结果喜忧参半。虽然成功或失败的原因总是很多,但我们观察到,这些数字医疗市场比典型的消费者或技术市场更复杂。而医疗保健领域的任何解决方案都需要以患者为中心;此外,医疗市场还需要对由医生和提供者组成的支持性生态系统或网络有深刻的理解和理解;以及付款人和监管机构的限制。必须理解和解决生态系统每个成员的价值主张。为了应对这一挑战,我们主张组建一个综合的多学科商业化团队,解决公司生命周期中的多维价值主张。重要的是,该团队应协同工作,并将服务设计作为关键团队成员,以及技术、业务、营销、报销和监管组成部分。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号